BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial-Reference-Cited by-同舟云学术

BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

Published:2017-04-19 Issue:7 Volume:32 Page:1496-1504
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Glorieux Francis H¹^ORCID,Devogelaer Jean-Pierre²,Durigova Michaela¹,Goemaere Stefan³,Hemsley Sarah⁴,Jakob Franz⁵,Junker Uwe⁴,Ruckle Jon⁶,Seefried Lothar⁵,Winkle Peter J⁷

Affiliation:

1. Research Centre; Shriners Hospital for Children, and McGill University; Montreal QC Canada

2. Université Catholique de Louvain; Saint-Luc University Hospital; Brussels Belgium

3. Ghent University Hospital; Ghent Belgium

4. Novartis Institutes for BioMedical Research; Basel Switzerland

5. Orthopedic Center for Musculoskeletal Research; Experimental and Clinical Osteology; Orthopedic Department; University of Wuerzburg; Wuerzburg Germany

6. Pacific Pharma Group; Tacoma WA USA

7. Anaheim Clinical Trials; Anaheim CA USA

Funder

Novartis Institutes for BioMedical Research

Noëlle L O'Regan

Mereo BioPharma

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Osteogenesis imperfecta;Glorieux;Best Pract Res Clin Rheumatol,2008